Article
[Optimizing antidepressant pharmacotherapy in a case of inflammatory bowel disease and major depression].
Psychiatrische Praxis - 1 Jul 2012
Schmidt Frank Martin, Tennert Carsten, Teupser Daniel, Himmerich Hubertus
Abstract excerpt
OBJECTIVE: In the framework of a case report on a patient suffering from major depression and inflammatory bowel disease we address the pharmacotherapeutical options in case of subtherapeutic mirtazapine levels. METHODS: We applied therapeutic drug monitoring (TDM) and cytochrome P450 2D6 genotyp...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
